Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of a patient-oriented navigation programme for patients with lung cancer or stroke in Germany: Protocol of the CoreNAVI study.
Gödde K, Fügemann H, Goerling U, Grittner U, Kohl R, Meisel A, Reinhold T, Schnitzer S, Deckert PM, Frost N, Schreiber SJ, Rieckmann N, Holmberg C. Gödde K, et al. Among authors: frost n. PLoS One. 2023 Jun 29;18(6):e0287638. doi: 10.1371/journal.pone.0287638. eCollection 2023. PLoS One. 2023. PMID: 37384672 Free PMC article.
Can routine register data be used to identify vulnerable lung cancer patients of suboptimal care in a German comprehensive cancer centre?
Gödde K, Siegerink B, Fügemann H, Keune D, Sander S, Schneider A, Müller-Nordhorn J, Holmberg C, Rieckmann N, Frost N, Keilholz U, Goerling U. Gödde K, et al. Among authors: frost n. Eur J Cancer Care (Engl). 2021 Jul;30(4):e13398. doi: 10.1111/ecc.13398. Epub 2021 Jan 15. Eur J Cancer Care (Engl). 2021. PMID: 33452721
Lung Cancer in Germany.
Frost N, Griesinger F, Hoffmann H, Länger F, Nestle U, Schütte W, Wolf J, Reck M. Frost N, et al. J Thorac Oncol. 2022 Jun;17(6):742-750. doi: 10.1016/j.jtho.2022.03.010. J Thorac Oncol. 2022. PMID: 35623674 Free article. No abstract available.
Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patients.
Frost N, Tessmer A, Schmittel A, van Laak V, Raspe M, Ruwwe-Glösenkamp C, Brunn M, Senger C, Böhmer D, Ochsenreither S, Temmesfeld-Wollbrück B, Furth C, Schmidt B, Neudecker J, Rückert JC, Suttorp N, Witzenrath M, Grohé C. Frost N, et al. Lung Cancer. 2018 Nov;125:164-173. doi: 10.1016/j.lungcan.2018.09.021. Epub 2018 Sep 25. Lung Cancer. 2018. PMID: 30429016
Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non-Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical Resection.
Wasilewski D, Radke J, Xu R, Raspe M, Trelinska-Finger A, Rosenstock T, Poeser P, Schumann E, Lindner J, Heppner F, Kaul D, Suttorp N, Vajkoczy P, Frost N, Onken J. Wasilewski D, et al. Among authors: frost n. JAMA Netw Open. 2022 Apr 1;5(4):e229553. doi: 10.1001/jamanetworkopen.2022.9553. JAMA Netw Open. 2022. PMID: 35486401 Free PMC article.
Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.
Frost N, Kollmeier J, Misch D, Vollbrecht C, Grah C, Matthes B, Pultermann D, Olive E, Raspe M, Ochsenreither S, von Laffert M, Suttorp N, Witzenrath M, Grohé C. Frost N, et al. Clin Lung Cancer. 2021 Sep;22(5):411-422. doi: 10.1016/j.cllc.2021.02.001. Epub 2021 Feb 6. Clin Lung Cancer. 2021. PMID: 33648877
Pathologic responses in oligometastatic NSCLC patients treated with neoadjuvant immune checkpoint blockade with and without chemotherapy followed by surgery.
Boch T, Frost N, Sommer L, Overbeck TR, Michaeli CT, Szuszies CJ, Rieckmann LM, Beumer N, Imbusch CD, Winter H, Thomas M, Roeper J, Janning M, Griesinger F, Wermke M, Loges S. Boch T, et al. Among authors: frost n. Lung Cancer. 2022 Feb;164:46-51. doi: 10.1016/j.lungcan.2021.11.009. Epub 2021 Nov 23. Lung Cancer. 2022. PMID: 34998106
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR.
Geßner C, Fietz T, Losem C, Lück A, Schulz H, Niemeier B, Groschek M, Eschenburg H, Weide R, Kretzschmar A, Frost N, Hipp J, Harde J, Matillon CD, Grebhardt S, Potthoff K. Geßner C, et al. Among authors: frost n. Curr Med Res Opin. 2022 Dec;38(12):2191-2199. doi: 10.1080/03007995.2022.2113693. Epub 2022 Sep 1. Curr Med Res Opin. 2022. PMID: 36047998 Clinical Trial.
Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis.
Schlachtenberger G, Schallenberg S, Doerr F, Menghesha H, Gaisendrees C, Amorin A, Grathwohl C, Büttner R, Quaas A, Horst D, Klauschen F, Frost N, Rueckert JC, Neudecker J, Höpker K, Wahlers T, Hekmat K, Heldwein MB. Schlachtenberger G, et al. Among authors: frost n. Eur J Cardiothorac Surg. 2023 Jul 3;64(1):ezad247. doi: 10.1093/ejcts/ezad247. Eur J Cardiothorac Surg. 2023. PMID: 37369037
204 results